Phase 2 Study of KH001 in Long-term Relief From Dentin Hypersensitivity

Completed · Phase 2 · Has a placebo group

Conditions studied: Dentin Hypersensitivity

In brief

The purpose of this study is to evaluate the efficacy and safety of KH001 in subjects with dentin hypersensitivity.

Key facts

Study ID

NCT06464939

Run by

HysensBio Co., Ltd

People needed

120

Starts

2024-10-08

Expected to finish

2025-12-22

Last updated by the study team

2026-01-13

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Is at least 18 years old by the time of the screening visit
• Is in good general health as determined by the investigator
• Has at least 2 non-adjacent teeth and is diagnosed with hypersensitive

You may not qualify if…

• Is allergic to the active drug substance or other excipients used in the investigational product
• Has any history of alcohol or drug abuse
• Has received any treatment related to dentin hypersensitivity within 8 weeks prior to the screening visit
• Is jedged by the investigator as ineligible for participation for other reasons

Where it is running

• ADA Forsyth — Cambridge, Massachusetts, United States
• Forsyth Institute — Cambridge, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.